Información*
| Nombre | MARIA DEL ROCIO MARTINEZ ALVARADO |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | INVESTIGACIÓN MÉDICA |
| Disciplina | ENDOCRINOLOGÍA |
| Especialidad | PEDIATRA |
| CVU | 597275 |
| Institución | |
|---|---|
| Dependencia | SIN INFORMACIÓN |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2023 |
| Fin: 31/12/2027 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2025
- Long COVID Patients with Orthostatic Intolerance Have Reduced Heart Rate Variability and Preserved Physiological Response to Active Standing Biology
- Left ventricular mass and systolic function in children environmentally exposed to fluoride Environmental Research
- Cohorte de 8 años en pacientes con psoriasis y síndrome metabólico Revista Hospital Medicine and Clinical Management
- Visceral adipose tissue is associated with recurrent cardiovascular events in premature coronary artery disease: sub-analysis of the GEA study cohort European Journal of Preventive Cardiology
- 2024
- Involvement of Expression of miR33-5p and ABCA1 in Human Peripheral Blood Mononuclear Cells in Coronary Artery Disease International Journal of Molecular Sciences
- Low HDL-C/ApoA-I index is associated with cardiometabolic risk factors and coronary artery calcium: a sub-analysis of the genetics of atherosclerotic disease (GEA) study BMC Endocrine Disorders
- Impact of Lipids and Vascular Damage on Early Atherosclerosis in Adolescents with Parental Premature Coronary Artery Disease High Blood Pressure & Cardiovascular Prevention
- 2023
- Increased carotid intima-media thickness and cardiometabolic risk factors are associated with IL-6 gene polymorphisms in Mexican individuals: The GEA Mexican study Biomolecules and Biomedicine
- Overexpression of microRNA-21-5p and microRNA-221-5p in Monocytes Increases the Risk of Developing Coronary Artery Disease International Journal of Molecular Sciences
- Senescent CD4+CD28null cells are increased in chronic hyperuricemia, show aberrant effector phenotypes, and are reversed after allopurinol therapy: a proof-of-concept pilot study Clinical Rheumatology
